Oncology practices enter 2026 facing some of the biggest updates in billing and compliance noted over recent years. Below is a breakdown of the key CMS 2026 Compliance Changes and what they mean for your practice, including how the right oncology billing company can keep you aligned with evolving standards.
ASP Reporting Updates: What’s Changing in 2026
CMS continues to tighten how drug pricing data is reported and used in the calculation of reimbursement, specifically for high-cost oncology medications. This means that manufacturers must report data more frequently and in greater detail. To the oncology practice, this translates to:
- More frequent changes in permissible reimbursement rates
- Tighter alignment of the acquisition cost and payment
- Practices relying on drug mark-up to sustain revenues are also likely to face increased pressure.
- Poor documentation can heighten audit exposure.
Practices must establish internal systems that account for the reconciliation of medication acquisition, wastage, administration, and billing with greater precision to protect revenue.
New Infusion Compliance Expectations
Infusion billing remains one of the most complex areas in oncology billing. In this regard, more stringent requirements for supervision have been implemented for certain infusion services. Accurate infusion billing will depend on:
- Specific start and end times
- Proper sequencing of initial, subsequent, and concurrent infusions
- Proper mapping of drug categories to the appropriate HCPCS codes
- Documentation of wastage in accordance with new ASP-related policies
Modifier and Coding Updates Oncology Practices Must Follow
The following are the trends likely to be faced by the oncology providers in the year 2026:
- Updated drug administration codes
- New or revised modifiers related to wastage, unused drugs, and multi-channel infusions
- Expanded use of modifiers; tighter reporting expectations
- Updates to drug-specific HCPCS codes
Incorrect or missing modifiers will be one of the most frequent causes of denials under the new CMS structure. Therefore, it is critically important to have internal coding audits performed to prevent revenue leakage.
Increased Audit Activity Focused on Oncology
Taken altogether, CMS has identified oncology as a high-risk specialty because of its very expensive drug portfolio and the complicated nature of billing patterns. In 2026, oncology practices should expect heightened scrutiny in:
- Incorrect units of drugs billed
- Discrepancies between inventory and claims
- Improper waste documentation
- Inaccurate infusion start/stop times
- Incorrect care claims
- Billing for drugs without documented medical necessity
Operational Challenges Oncology Practices Will Face
Taken together, these updates will contribute to a set of operational burdens:
- Increased administrative time due to coding and documentation
- Higher risk for denials related to drug calculations and unit mistakes
- Reduced margins through acquisition costs rising faster than reimbursement
- Disrupted cash flow when frequent resubmission of claims becomes necessary
- More labor hours involved in reconciling drug inventory with billing
These challenges can greatly affect the financial viability of smaller oncology practices unless these systems are upgraded and workflows modernized.
How an Oncology Billing Company Helps Practices Stay Compliant in 2026
With the rise in complexity, many oncology groups opt to work with specialized billing partners. A qualified oncology billing company like RCM Workshop offers the following support:
- Stay updated on CMS fee schedule changes.
- Expert coding for infusion, chemo administration, and biologics.
- Proper modifier use to prevent denials.
- Audit-ready documentation support.
- Compliance monitoring aligned with new CMS standards.
The ASP reporting and infusion compliance changes arriving in 2026 continue the trend of reshaping how oncology practices bill, document, and manage their high-cost drug workflows. Shrinking margins and increased scrutiny make precision more crucial than ever. Stay ahead of the 2026 CMS compliance changes by strengthening your processes with experts such as RCM Workshop for perfect oncology billing compliance.
